In this episode we have a repeat guest, Dr.Leonard Pastrana from NuBioAge. We catch up on what’s happened in his business this last year, and the services they offer to providers. Together we dive into some of our favorite recovery and body composition peptides, as well as the new (𝗚𝗟𝗣-𝟭 𝗥𝗔𝘀) to hit the diabetic world. This new peptide, labeled Tirzepatide, marketed as Mounjaro, is a new injectable medication initially indicated for diabetes and now for obesity. This emerging drug is the first dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor, an agonist.

Be sure to catch the end of the episode for peptide tips, trouble shooting, and common questions we get!

Follow: Dr.Pastrana @leonardpastrana and @nubioagewellnessnetwork